ATLANTA, GA – – (Newsfile Corp. – September 20, 2022) – – Holzer & Holzer, LLC informs investors that a class action lawsuit was filed against Co-Diagnostics, Inc. (“Co-Diagnostics” or the “Company”) (NASDAQ: CODX).  The lawsuit alleges Co-Diagnostics made materially false and misleading statements and/or failed to disclose material adverse facts about its Logix Smart™ COVID-19 Test, including: (1) demand for the Logix Smart™ COVID-19 Test had plummeted throughout the quarter ended June 30, 2022, and (2) as a result, the Company’s positive statements about the demand for this product lacked a reasonable basis.


If you bought shares of Co-Diagnostics between May 12, 2022 and August 11, 2022, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey Holzer, Esq. at or Joshua Karr, Esq. at, by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at to learn more.


The deadline to ask the court to be appointed lead plaintiff in the case is October 17, 2022.


Registration Deadline

Lead Plaintiff Deadline Has Passed

October 17, 2022

Submit Your Information

Shares Purchased
Date Puchased
Number of Shares Acquired
Acquisition Price Per Share
Shares Sold
Date Sold
Number of Shares Sold
Selling Price Per Share
By clicking on the button below, I am requesting Holzer & Holzer, LLC send me documents necessary to retain the firm.